MacroPore Biosurgery develops and manufactures bioresorbable surgical implants.
History:
Fouded in June 1996 as MacroPore. They acquired StemSource in 2002 and have since changed their name to Cytori Therapeutics. MacroPore Biosurgery now operates as a division of the new company.
